Today, International Stem Cell Corporation announced that it will collaborate with renowned stem cell researcher Jeanne F. Loring, Ph.D. and the Scripps Research Institute (located in La Jolla, CA) to study parthenogenetic stem cells and their potentially derived therapeutic cells. The study expands the company’s mission to generate data necessary to understand these cells and move them closer to the clinic.

ISCO has perfected a process using unfertilized human eggs to creating human stem cells. These “parthenogenetic” stem cells allow immune-matching to large segments of the population. ISCO’s process allows the company to avoid the ethical debate regarding the use of human embryos.

Company scientists have derived a type of cell found in the human eye from parthenogenetic stem cells that may have application in the treatment of macular degeneration, a common eye disease. Dr. Loring and ISCO will study these cells as part of the collaboration.

According to

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday October 2, 2009

DrStockPick.com Stock Report!

**************************************************************

Integral Systems, Inc., (Nasdaq: ISYS) today announced its continued partnership with the US Air Force on the Rapid Attack, Identification, Detection and Reporting System Block-10 (RAIDRS RB-10) program. On September 25, the US Air Force Space and Missile Systems Center obligated $27,740,754 to implement the restructure of the program from a 6 fixed and 3 deployable site configuration, to a 5 transportable system construct. The Air Force has approved the system restructure under a contract modification with a ceiling